CIK 0000921114 · Non-accelerated filer<br>Smaller reporting company
Armata Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ARMP
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- operating
- EIN
- 911549568
- Phone
- 310-665-2928
- Business address
- 5005 MCCONNELL AVE, LOS ANGELES, CA, 90066
- Former names
- AmpliPhi Biosciences Corp, TARGETED GENETICS CORP /WA/
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 70,000 shares (grant or award)
- 4 Grant or award Director acquired 50,000 shares (grant or award)
- 4 Shares withheld for taxes Vice President and CFO gave up 66,125 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 99,187 shares (to pay taxes)
- 4 Open-market sale 10% owner sold 875,000 shares at an average $0.26 ($227,398)
- 4 Open-market sale 10% owner sold 1,320,481 shares at an average $0.27 ($357,551)
- 4 Open-market sale 10% owner sold 160,000 shares at an average $0.51 ($81,626)
- 4 Open-market sale 10% owner sold 146,452 shares at an average $0.05 ($7,378)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 9 of 14 · 267 filings